Beatriz Gros

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 17

Top Venues

Alimentary pharmacology & therapeutics

Biomedicines

Cancers

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Iria Bastón-Rey, Iago Rodríguez-Lago, Ana María Luque, Berta Caballol, Carlos Soutullo-Castiñeiras, Ana Bravo, Andrés Castaño, Beatriz Gros, Lorena Bernal, María Teresa Diz-Lois, Horacio Alonso-Galán, Fiorella Cañete, Beatriz Castro, Pablo Pérez-Galindo, Carlos González-Muñoza, Ismael El Hajra, Pilar Martínez-Montiel, Inmaculada Alonso-Abreu, Francisco Mesonero Gismero, María González-Vivo, Laia Peries, Eduardo Martín-Arranz, Carlos Abril, Ignacio Marín-Jiménez, Ruth Baltar, Miren Vicuña, Nadia Moreno, Eduard Brunet, Cristina Rubín de Célix, Ingrid Fajardo, Noelia Cruz, Cristina Calvino-Suárez, María Rojas-Feria, Agnes Fernández-Clotet, Marta Gimeno-Torres, Laura Nieto-Garcia, Daniel de la Iglesia, Yamile Zabana, Cristina Suárez-Ferrer, Manuel Barreiro-de Acosta
The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU. Inflammatory bowel diseases (2024)
Beatriz Gros, Hannah Ross, Maureen Nwabueze, Nathan Constantine-Cooke, Lauranne A A P Derikx, Mathew Lyons, Claire O'Hare, Colin Noble, Ian D Arnott, Gareth-Rhys Jones, Charlie W Lees, Nikolas Plevris
Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis. Therapeutic advances in gastroenterology 17 (2024)
Beatriz Gros, Hannah Ross, Maureen Nwabueze, Nathan Constantine-Cooke, Lauranne A A P Derikx, Mathew Lyons, Claire O'Hare, Colin Noble, Ian D Arnott, Gareth-Rhys Jones, Charlie W Lees, Nikolas Plevris
Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis. Therapeutic advances in gastroenterology 17 (2024)
Beatriz Gros, Mairi Goodall, Nik Plevris, Nathan Constantine-Cooke, Alexander Thomas Elford, Claire O'Hare, Colin Noble, Gareth-Rhys Jones, Ian D Arnott, Charlie W Lees
Real-World Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis. Journal of Crohn's & colitis (2023)
Yasmin Zurba, Beatriz Gros, Mohammad Shehab
Exploring the Pipeline of Novel Therapies for Inflammatory Bowel Disease; State of the Art Review. Biomedicines 11 (3) (2023)
María José Casanova, Óscar Nantes, Pilar Varela, Milagros Vela-González, Montserrat Rivero, Olivia Sierra-Gabarda, Sabino Riestra, Manuel Barreiro-de Acosta, María Del Mar Martín-Rodríguez, Carla Jerusalén Gargallo-Puyuelo, Cristina Reygosa, Roser Muñoz, Irene García de la Filia-Molina, Andrea Núñez-Ortiz, Lilyan Kolle, Margalida Calafat, Jose Maria Huguet, Eva Iglesias-Flores, Teresa de Jesús Martínez-Pérez, Orencio Bosch, José María Duque-Alcorta, Santiago Frago-Larramona, Manuel Van Domselaar, Víctor Manuel González-Cosano, Luis Bujanda, Saioa Rubio, Alejo Mancebo, Beatriz Castro, Santiago García-López, Ruth de Francisco, Laura Nieto-García, Viviana Laredo, Ana Gutiérrez-Casbas, Francisco Mesonero Gismero, Eduardo Leo-Carnerero, Fiorella Cañete, Lucía Ruiz, Beatriz Gros, María Del Moral-Martínez, Cristina Rodríguez, Maria Chaparro, Francisco Javier García-Alonso
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study. Alimentary pharmacology & therapeutics (2023)
Beatriz Gros, Alberto Gómez Pérez, María Pleguezuelo, Francisco Javier Serrano Ruiz, Manuel de la Mata, Manuel Luis Rodríguez-Perálvarez
Helicobacter Species and Hepato-Biliary Tract Malignancies: A Systematic Review and Meta-Analysis. Cancers 15 (3) (2023)
Rosario Medina-Medina, Eva Iglesias-Flores, Jose M Benítez, Sandra Marín-Pedrosa, Isabel Salgueiro-Rodríguez, Clara I Linares, Sandra González-Rubio, Pilar Soto-Escribano, Beatriz Gros, Manuel Luis Rodríguez-Perálvarez, José Luis Cabriada, Maria Chaparro, Francisco Javier García-Alonso, Eduardo Chicano-Gálvez, Ignacio Ortea, Gustavo Ferrín, Valle García-Sánchez, Patricia Aguilar-Melero
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs. International journal of molecular sciences 24 (10) (2023)
Beatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian D Arnott, Gareth-Rhys Jones, Charlie W Lees, Lauranne A A P Derikx
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort. United European gastroenterology journal (2023)
Yasmin Zurba, Beatriz Gros, Mohammad Shehab
Exploring the Pipeline of Novel Therapies for Inflammatory Bowel Disease; State of the Art Review. Biomedicines 11 (3) (2023)
María José Casanova, Óscar Nantes, Pilar Varela, Milagros Vela-González, Montserrat Rivero, Olivia Sierra-Gabarda, Sabino Riestra, Manuel Barreiro-de Acosta, María Del Mar Martín-Rodríguez, Carla Jerusalén Gargallo-Puyuelo, Cristina Reygosa, Roser Muñoz, Irene García de la Filia-Molina, Andrea Núñez-Ortiz, Lilyan Kolle, Margalida Calafat, Jose Maria Huguet, Eva Iglesias-Flores, Teresa de Jesús Martínez-Pérez, Orencio Bosch, José María Duque-Alcorta, Santiago Frago-Larramona, Manuel Van Domselaar, Víctor Manuel González-Cosano, Luis Bujanda, Saioa Rubio, Alejo Mancebo, Beatriz Castro, Santiago García-López, Ruth de Francisco, Laura Nieto-García, Viviana Laredo, Ana Gutiérrez-Casbas, Francisco Mesonero Gismero, Eduardo Leo-Carnerero, Fiorella Cañete, Lucía Ruiz, Beatriz Gros, María Del Moral-Martínez, Cristina Rodríguez, Maria Chaparro, Francisco Javier García-Alonso
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study. Alimentary pharmacology & therapeutics (2023)
Beatriz Gros, Nikolas Plevris, Nathan Constantine-Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian D Arnott, Gareth-Rhys Jones, Charlie W Lees, Lauranne A A P Derikx
Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort. United European gastroenterology journal (2023)
María José Casanova, Óscar Nantes, Pilar Varela, Milagros Vela-González, Montserrat Rivero, Olivia Sierra-Gabarda, Sabino Riestra, Manuel Barreiro-de Acosta, María Del Mar Martín-Rodríguez, Carla Jerusalén Gargallo-Puyuelo, Cristina Reygosa, Roser Muñoz, Irene García de la Filia-Molina, Andrea Núñez-Ortiz, Lilyan Kolle, Margalida Calafat, Jose Maria Huguet, Eva Iglesias-Flores, Teresa de Jesús Martínez-Pérez, Orencio Bosch, José María Duque-Alcorta, Santiago Frago-Larramona, Manuel Van Domselaar, Víctor Manuel González-Cosano, Luis Bujanda, Saioa Rubio, Alejo Mancebo, Beatriz Castro, Santiago García-López, Ruth de Francisco, Laura Nieto-García, Viviana Laredo, Ana Gutiérrez-Casbas, Francisco Mesonero Gismero, Eduardo Leo-Carnerero, Fiorella Cañete, Lucía Ruiz, Beatriz Gros, María Del Moral-Martínez, Cristina Rodríguez, Maria Chaparro, Francisco Javier García-Alonso
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study. Alimentary pharmacology & therapeutics (2023)
María José Casanova, Óscar Nantes, Pilar Varela, Milagros Vela-González, Montserrat Rivero, Olivia Sierra-Gabarda, Sabino Riestra, Manuel Barreiro-de Acosta, María Del Mar Martín-Rodríguez, Carla Jerusalén Gargallo-Puyuelo, Cristina Reygosa, Roser Muñoz, Irene García de la Filia-Molina, Andrea Núñez-Ortiz, Lilyan Kolle, Margalida Calafat, Jose Maria Huguet, Eva Iglesias-Flores, Teresa de Jesús Martínez-Pérez, Orencio Bosch, José María Duque-Alcorta, Santiago Frago-Larramona, Manuel Van Domselaar, Víctor Manuel González-Cosano, Luis Bujanda, Saioa Rubio, Alejo Mancebo, Beatriz Castro, Santiago García-López, Ruth de Francisco, Laura Nieto-García, Viviana Laredo, Ana Gutiérrez-Casbas, Francisco Mesonero Gismero, Eduardo Leo-Carnerero, Fiorella Cañete, Lucía Ruiz, Beatriz Gros, María Del Moral-Martínez, Cristina Rodríguez, Maria Chaparro, Francisco Javier García-Alonso
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study. Alimentary pharmacology & therapeutics (2023)
Beatriz Gros, Alberto Gómez Pérez, María Pleguezuelo, Francisco Javier Serrano Ruiz, Manuel de la Mata, Manuel Luis Rodríguez-Perálvarez
Helicobacter Species and Hepato-Biliary Tract Malignancies: A Systematic Review and Meta-Analysis. Cancers 15 (3) (2023)
Beatriz Gros, Pilar Soto, Manuel Causse, Sandra Marín, Eva Iglesias, Jose Manuel Benítez
Impact of Clostridioides difficile infection in patients admitted with ulcerative colitis. Scandinavian journal of gastroenterology (2022)
Beatriz Gros, Iago Rodriguez-Lago
Editorial: thiopurines in the multidrug era-time to rescue our memories over half a century of experience. Alimentary pharmacology & therapeutics 56 (6) (2022)

Beatriz Gros.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Beatriz Gros